News
Virax Biolabs Group
VRAX · NASDAQ
$1.22−$0.015 (−1.21%)TodayMarket closed ·
Prev close $1.23
Latest news
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Virax Biolabs Management Believes Current Valuation Doesn't Fully Reflect Its Audited Financial Position, Clinical And Development Programs, Commercial Progress Or Strategic Assets
- Press releasePRNewswire
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
- Press releasePRNewswire
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
- NewsAvi Kapoor
Dow Gains 50 Points; Simulations Plus Earnings Top Views
- Press releaseGlobe Newswire
These Companies Just Dropped Major Growth Catalysts
- NewsAvi Kapoor
US Stocks Edge Higher; Delta Air Lines Posts Upbeat Q2 Earnings
- Press releasePRNewswire
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
- NewsAvi Kapoor
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 Results
- NewsVandana Singh
Why Did Virax Biolabs Stock Triple In One Session?
- NewsAvi Kapoor
Nasdaq Gains 100 Points; US Initial Jobless Claims Edge Lower
- News
Virax Biolabs Group Unit Enters Into Exclusive Multi-Country Commercial Supply Agreement With Fosun Diagnostics For ImmuneSelect Research-Use Immune Profiling Product Line
- Press releasePRNewswire
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
- Press releasePRNewswire
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
- Press releasePRNewswire
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsMohd Haider
Why Is Virax Biolabs (VRAX) Stock Trending Overnight?
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- NewsAvi Kapoor
Nasdaq Down 200 Points; Brady Earnings Top Views
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releasePRNewswire
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders
- NewsAvi Kapoor
Dow Dips Over 350 Points; Goldman Sachs Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAlex Perry
What's Behind The Jump In Virax Biolabs Stock?
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releasePRNewswire
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Gains 1%; Macy's Reports Strong Q3 Results
- NewsAvi Kapoor
US Stocks Mixed; Dollar Tree Posts Upbeat Earnings
- NewsChris Katje
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.